Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRα

被引:45
作者
Lehrke, M
Lebherz, C
Millington, SC
Guan, HP
Millar, J
Rader, DJ
Wilson, JM
Lazar, MA [1 ]
机构
[1] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Div Med Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Div Cardiol, Dept Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.cmet.2005.04.005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The high-cholesterol/high-fat Western diet has abetted an epidemic of atherosclerotic cardiovascular disease, the leading cause of death in industrialized nations. Liver X receptors (LXRs) are oxysterol sensors that are required for normal cholesterol and triglyceride homeostasis, yet synthetic LXR agonists produce undesirable hypertriglyceridemia. Here we report a previously unrecognized role for hepatic LXR alpha in the links between diet, serum lipids, and atherosclerosis. A modest increase in hepatic LXR alpha worsened serum lipid profiles in LDL-receptor null mice fed normal chow but had the opposite effect on lipids and afforded strong protection against atherosclerosis on a Western diet. The beneficial effect of hepatic LXR alpha was abrogated by a synthetic LXR agonist, which activated SREBP-1c and its target genes. Thus, the interplay between diet and hepatic LXR alpha is a critical determinant of serum lipid profiles and cardiovascular risk, and selective modulation of LXR target genes in liver can ameliorate hyperlipidemia and cardiovascular disease.
引用
收藏
页码:297 / 308
页数:12
相关论文
共 52 条
[21]   HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY [J].
ISHIBASHI, S ;
BROWN, MS ;
GOLDSTEIN, JL ;
GERARD, RD ;
HAMMER, RE ;
HERZ, J .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) :883-893
[22]   The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c [J].
Jakel, H ;
Nowak, M ;
Moitrot, M ;
Dehondt, H ;
Hum, DW ;
Pennacchio, LA ;
Fruchart-Najib, J ;
Fruchart, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :45462-45469
[23]   An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha [J].
Janowski, BA ;
Willy, PJ ;
Devi, TR ;
Falck, JR ;
Mangelsdorf, DJ .
NATURE, 1996, 383 (6602) :728-731
[24]   Synthetic LXR ligand inhibits the development of atherosclerosis in mice [J].
Joseph, SB ;
McKilligin, E ;
Pei, LM ;
Watson, MA ;
Collins, AR ;
Laffitte, BA ;
Chen, MY ;
Noh, G ;
Goodman, J ;
Hagger, GN ;
Tran, J ;
Tippin, TK ;
Wang, XP ;
Lusis, AJ ;
Hsueh, WA ;
Law, RE ;
Collins, JL ;
Willson, TM ;
Tontonoz, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7604-7609
[25]   Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia [J].
Lebherz, C ;
Gao, GP ;
Louboutin, JP ;
Millar, J ;
Rader, D ;
Wilson, JM .
JOURNAL OF GENE MEDICINE, 2004, 6 (06) :663-672
[26]   Macrophage liver x receptor is required for antiatherogenic activity of LXR agonists [J].
Levin, N ;
Bischoff, ED ;
Daige, CL ;
Thomas, D ;
Vu, CT ;
Heyman, RA ;
Tangirala, RK ;
Schulman, IG .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (01) :135-142
[27]   CHOLESTEROL REDUCTION IN CARDIOVASCULAR-DISEASE - CLINICAL BENEFITS AND POSSIBLE MECHANISMS [J].
LEVINE, GN ;
KEANEY, JF ;
VITA, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (08) :512-521
[28]   PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis [J].
Li, AC ;
Glass, CK .
JOURNAL OF LIPID RESEARCH, 2004, 45 (12) :2161-2173
[29]   Liver X receptors (LXRs) regulate apolipoprotein AIV-implications of the antiatherosclerotic effect of LXR agonists [J].
Liang, Y ;
Jiang, XC ;
Liu, RJ ;
Liang, GS ;
Beyer, TP ;
Gao, H ;
Ryan, TP ;
Li, SYD ;
Eacho, PI ;
Cao, GQ .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (08) :2000-2010
[30]   Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β cactivation of SREBP [J].
Lin, JD ;
Yang, RJ ;
Tarr, PT ;
Wu, PH ;
Handschin, C ;
Li, SM ;
Yang, WL ;
Pei, LM ;
Uldry, M ;
Tontonoz, P ;
Newgard, CB ;
Spiegelman, BM .
CELL, 2005, 120 (02) :261-273